Clinical Trials Browser

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT06660862 2026-01-08

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Phase 4 Not yet recruiting

80 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06980103 2026-01-08

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Phase NA Recruiting

408 enrolled

Head & Neck

Thyroid Neoplasms

NCT07312760 2025-12-31

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Phase NA Recruiting

160 enrolled

Death, Pyloric Stenosis, Hypertrophic

NCT07307456 2025-12-29

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Phase 2 Recruiting

31 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07301424 2025-12-24

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

Phase 2 Not yet recruiting

80 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04345718 2025-12-09

EXHITENTRE

Phase 2/3 Completed

344 enrolled

Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders

NCT07181278 2025-12-02

OptiTri_MT

Phase NA Recruiting

1,180 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02023463 2025-11-25

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Phase 1 Active not recruiting

25 enrolled

Genitourinary

Prostatic Neoplasms

NCT07239622 2025-11-20

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Phase 2 Not yet recruiting

36 enrolled

Gynecologic

Ovarian Neoplasms

NCT07091032 2025-11-18

Building Connections

Phase NA Recruiting

3,600 enrolled

GastrointestinalGynecologicOther

Anxiety Disorders, Uterine Cervical Neoplasms, Colonic Neoplasms, Depression, Obesity

NCT06180460 2025-10-08

CALM: Managing Distress in Malignant Brain Cancer

Phase NA Completed

60 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT06582784 2025-10-07

IMPACT

Phase NA Recruiting

279 enrolled

Depression, Neoplasms

NCT07180901 2025-09-18

PRONTO-HN

Phase NA Recruiting

85 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT00819208 2025-09-16

CHALLENGE

Phase NA Active not recruiting

889 enrolled

Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT04961047 2025-09-15

Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

Phase NA Completed

36 enrolled

Depression

NCT07137819 2025-08-22

EXACT-1

Phase 3 Recruiting

280 enrolled

Dermatologic

Keratosis, Actinic

NCT06947577 2025-08-20

PEMFTEPCHIN

Phase 4 Completed

80 enrolled

Agnosia

NCT06057675 2025-08-19

Tranexamic Acid in Nasal Mohs Reconstruction

Phase 2 Recruiting

100 enrolled

Postoperative Hemorrhage

NCT07130942 2025-08-19

Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Response - in Vivo/in Vitro Studies

Phase NA Not yet recruiting

250 enrolled

Respiratory Aspiration

NCT05655546 2025-08-08

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Phase NA Terminated

2,117 enrolled 6 charts

LymphoidOther hematologic neoplasmPlasma cell

COVID-19, Graft vs Host Disease, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Multiple Myeloma, Neoplasms, HIV Infections

NCT07110259 2025-08-07

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

Phase NA Not yet recruiting

950 enrolled

Thoracic

Non Small Cell Lung Caner

NCT05444348 2025-07-29

ACT

Phase NA Recruiting

920 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06765707 2025-07-24

SyMPTOM

Phase NA Enrolling by invitation

225 enrolled

Breast

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Clinical Trials

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

SNIFF

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

STOP-CLL-DCT

CARES-Lite

PBM-LEF

Evolut™ EXPAND TAVR II Pivotal Trial

STEPS-BC

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

INSPIRE

ARETHUSA

Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis

FOCALE

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Niraparib In Recurrent IDH 1/2 Gliomas

Cervical Thermal Ablation to Treat Persistent HPV Infection

A-319

Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma

Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Epithelial Ovarian Cancer.

CRANIO4US

Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.

Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer

Existential Distress in Advanced Cancer: Comparing a Short-term Psychodynamic Psychotherapy (ORPHYS) to Treatment as Usual (TAU)

Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

EXHITENTRE

OptiTri_MT

Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer

Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma

Building Connections

CALM: Managing Distress in Malignant Brain Cancer

IMPACT

PRONTO-HN

CHALLENGE

Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer Survivors

EXACT-1

PEMFTEPCHIN

Tranexamic Acid in Nasal Mohs Reconstruction

Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Response - in Vivo/in Vitro Studies

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

AI-Based DeepGEM Tool for Predicting Gene Mutations in NSCLC Patients: A Randomized Controlled Study

ACT

SyMPTOM